Private hospital operator RHC warned the market last week that COVID restrictions would have a material impact on its FY22 earnings e.g. in the first quarter it hit revenue by $55m. Obviously this is not good news but it shouldn’t be regarded as a surprise more a potential opportunity. MM has been monitoring RHC for a few weeks and we have definite interest in this quality business around 6-8% lower.
Overnight RHC has reached an agreement with the National Health Service (NHS) in the UK to assist with the increased demands from COVID, a move which we don’t believe will have a material impact on the share price.